Local view for "https://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/Evidence/1530"

Predicate	Value (sorted: default)
rdfs:label	"evidence_1201"
rdf:type	?:Evidence ?:Item
?:Evidence_enzyme_system	""
?:Evidence_type	?:Non_Tracable_Statement
?:content	"The FDA lists this as a accepted in vivo probe substrate for CY2C8 PK clinical trials in this guidance document. See Table 2, p. 22"
dc:creator	"boycer"
dc:date	"10/29/2007 11:08:59"
rdfs:seeAlso	?:FDA-Guidance-Drug-Interaction-Studies%E2%80%93Study%20Design-Data-Analysis-and-Implications-2006.pdf

All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines/dikb.ttl

The resource appears as object in one triple:

{ rosiglitazone_primary_total_clearance_enzyme_cyp2c8, <http://purl.org/swan/1.2/swan-commons#citesAsSupportingEvidence>, evidence_1201 }

Context graph